Stem cell company DefininGEN raises £1.5m in follow-on funding
The new funding will enable DefiniGEN to deliver ground-breaking cryopreserved…
23 May 2016 | By Victoria White, Digital Content Producer
The new funding will enable DefiniGEN to deliver ground-breaking cryopreserved pancreatic beta cell products to the global diabetes drug development market...